Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jose Baselga, James Allison, Ronald Evans, Kathy Giusti, and more

Premium

The American Association for Cancer Research has named personalized breast cancer treatment expert Jose Baselga as its new president-elect. Baselga, physician-in-chief at Memorial Sloan Kettering Cancer Center, will become president-elect this coming April and assume the presidency in April 2015.

Baselga has been involved with AACR for two decades in many capacities, including as a member of the board of directors from 2009 to 2012. He is a leader of the Stand Up To Cancer Dream Team: Targeting the PI3K Pathway in Women’s Cancers. Before joining MSKCC, Baselga headed the division of hematology/oncology at the Massachusetts General Hospital Cancer Center, and was a professor of medicine at Harvard Medical School in Boston.

Additionally, AACR also elected five new members to its board of directors, including James Allison, chair of the immunology department at The University of Texas MD Anderson Cancer Center; Ronald Evans, chair of molecular and developmental biology at the Salk Institute for Biological Studies; Scott Lippman, director of the University of California, San Diego Moores Cancer Center; Guillermina Lozano, chair of the department of genetics at MD Anderson; and M. Celeste Simon, scientific director at the Abramson Family Cancer Research Institute, University of Pennsylvania.


Kathy Giusti, founder and CEO of the Multiple Myeloma Research Foundation, has received Research!America's 2014 Gordon and Llura Gund Leadership Award for advancing the research and treatment of multiple myeloma. Giusti was recently honored at the 2014 Advocacy Awards at the Andrew W. Mellon Auditorium in Washington, DC, for her innovative work in creating collaborative research models that incorporate genomic and other clinical information from multiple myeloma patients.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.